brl 55834 has been researched along with albuterol in 1 studies
| Studies (brl 55834) | Trials (brl 55834) | Recent Studies (post-2010) (brl 55834) | Studies (albuterol) | Trials (albuterol) | Recent Studies (post-2010) (albuterol) |
|---|---|---|---|---|---|
| 5 | 0 | 0 | 10,108 | 3,059 | 2,058 |
| Protein | Taxonomy | brl 55834 (IC50) | albuterol (IC50) |
|---|---|---|---|
| Beta-2 adrenergic receptor | Homo sapiens (human) | 1.2618 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arch, JR; Bowring, NE; Buckle, DR | 1 |
1 other study(ies) available for brl 55834 and albuterol
| Article | Year |
|---|---|
Evaluation of the novel potassium channel activator BRL 55834 as an inhaled bronchodilator in guinea-pigs and rats: comparison with levcromakalim and salbutamol.
Topics: Administration, Inhalation; Aerosols; Albuterol; Animals; Atmosphere Exposure Chambers; Benzopyrans; Blood Pressure; Bronchi; Bronchoconstriction; Bronchodilator Agents; Cromakalim; Drug Evaluation, Preclinical; Guinea Pigs; Histamine Antagonists; Male; Methacholine Chloride; Nebulizers and Vaporizers; Piperidones; Potassium Channels; Pyrroles; Rats; Rats, Sprague-Dawley | 1994 |